Open AccessBasiliximab Versus Daclizumab Combined With Triple Immunosuppression in Deceased Donor Renal Transplantation: A Prospective, Randomized Study
Author(s) -
A. Kandus,
Miha Arnol,
Katarina Omahen,
Manca Oblak,
B. VidanJeras,
Andrej Kmetec,
Andrej Bren
Publication year - 2010
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0b013e3181d02496
Subject(s) - daclizumab , basiliximab , medicine , immunosuppression , transplantation , urology , kidney transplantation , surgery , gastroenterology , tacrolimus
In this prospective, randomized, open-label, single-center study, we compared the efficacy and safety of two anti-interleukin-2 receptor monoclonal antibodies combined with triple immunosuppression.